Related references
Note: Only part of the references are listed.Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes:: A comparative study
Junxia Yao et al.
CLINICAL INFECTIOUS DISEASES (2008)
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects
Mary K. Wloch et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses
Michael Schmitt et al.
BLOOD (2008)
Dendritic cell vaccination in allogeneic stem cell recipients: Induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor
Goetz Ulrich Grigoleit et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Reversible HLA multimers (Streptamers) for the isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens
Julia Neudorfer et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Patients at high risk for CMV infection and disease show delayed CD8+ T-cell immune recovery after allogeneic stem cell transplantation
S. Ganepola et al.
BONE MARROW TRANSPLANTATION (2007)
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers
M Cobbold et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis
G Haerter et al.
CLINICAL INFECTIOUS DISEASES (2004)
Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease
JF Poulin et al.
BLOOD (2003)
Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megatile analysis
P Ljungman et al.
BLOOD (2003)
Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles
SF Lacey et al.
HUMAN IMMUNOLOGY (2003)
Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer
M Knabel et al.
NATURE MEDICINE (2002)
Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy
H Einsele et al.
BLOOD (2002)
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation
K Cwynarski et al.
BLOOD (2001)
Share Paper
